High materiality8/10
H.C. Wainwright Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates Buy; target $70; posted price $40.25; priceChangeSinceSignal -6.45.
- Target: $70
- Posted price: $40.25
- Analyst firm: UBS
Key facts
- 01
Target: $70
- 02
Posted price: $40.25
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.